Next Article in Journal
Inhibitory Activity of Essential Oils of Mentha spicata and Eucalyptus globulus on Biofilms of Streptococcus mutans in an In Vitro Model
Previous Article in Journal
Antimicrobial Resistance, SCCmec, Virulence and Genotypes of MRSA in Southern China for 7 Years: Filling the Gap of Molecular Epidemiology
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 12
Issue 2
10.3390/antibiotics12020370
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence of Antimicrobial Resistance and Clonal Relationship in ESBL/AmpC-Producing Proteus mirabilis Isolated from Meat Products and Community-Acquired Urinary Tract Infection (UTI-CA) in Southern Brazil

by
Matheus Silva Sanches
1,
Luana Carvalho Silva
1,
Caroline Rodrigues da Silva
2,
Victor Hugo Montini
1,
Bruno Henrique Dias de Oliva
1,
Gustavo Henrique Migliorini Guidone
1,
Mara Corrêa Lelles Nogueira
2,
Maísa Fabiana Menck-Costa
3,
Renata Katsuko Takayama Kobayashi
3,
Eliana Carolina Vespero
4 and
Sergio Paulo Dejato Rocha
1,*
1
Laboratory of Bacteriology, Center of Biological Sciences, Department of Microbiology, State University of Londrina, Londrina P.O. Box 10.011, Brazil
2
Microorganism Research Center, Health Sciences Center, Department of Dermatological, Infectious and Parasitic Diseases, Medical School of São José do Rio Preto, São José do Rio Preto P.O. Box 15.090, Brazil
3
Laboratory of Basic and Applied Bacteriology, Center of Biological Sciences, Department of Microbiology, State University of Londrina, Londrina P.O. Box 10.011, Brazil
4
Department of Pathology, Health Sciences Center, Clinical and Toxicological Analysis, University Hospital of Londrina, State University of Londrina, Londrina P.O. Box 10.011, Brazil
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(2), 370; https://doi.org/10.3390/antibiotics12020370
Submission received: 19 December 2022 / Revised: 6 February 2023 / Accepted: 8 February 2023 / Published: 10 February 2023
Browse Figures
Versions Notes

Abstract

:
The present study aimed to evaluate the prevalence of antimicrobial resistance and clonal relationships in Proteus mirabilis isolated from chicken meat, beef, pork, and community-acquired urinary tract infections (UTI-CA). Chicken meat isolates showed the highest multidrug resistance (MDR), followed by those from pork and UTI-CA, whereas beef had relatively few MDR strains. All sources had strains that carried blaCTX-M-65, whereas blaCTX-M-2 and blaCMY-2 were only detected in chicken meat and UTI-CA isolates. This indicates that chicken meat should be considered an important risk factor for the spread of P. mirabilis carrying ESBL and AmpC. Furthermore, ESBL/AmpC producing strains were resistant to a greater number of antimicrobials and possessed more resistance genes than non-producing strains. In addition, the antimicrobial resistance genes qnrD, aac(6′)-Ib-cr, sul1, sul2, fosA3, cmlA, and floR were also found. Molecular typing showed a genetic similarity between chicken meat and UTI-CA isolates, including some strains with 100% similarity, indicating that chicken can be a source of P. mirabilis causing UTI-CA. It was concluded that meat, especially chicken meat, can be an important source of dissemination of multidrug-resistant P. mirabilis in the community.

1. Introduction

Proteus mirabilis is a Gram-negative bacterium belonging to the Morganellaceae and is commonly found in the environment, for example in soil and wastewater, in addition to being a commensal bacterium in the gut microbiota of humans and other animals [1]. It is classified as an opportunistic pathogen with several studies demonstrating its potential to cause infections. Urinary tract infections (UTIs), both nosocomial and community acquired (UTI-CA), are the most prevalent and persistent infections caused by P. mirabilis [2,3]. Although the prevalence may vary by region, P. mirabilis is among the most commonly isolated enterobacteria in UTI cases [4] and has been reported as the second most prevalent enterobacteria in a study in southern Brazil, trailing only behind Escherichia coli [5].
The intestinal tracts of several animals, such as broiler chickens, act as reservoirs for P. mirabilis [6], which may allow the transfer of these bacteria to the slaughter line, especially during evisceration of carcasses [7,8]. The isolation of P. mirabilis in food has been poorly documented; however, some studies have reported its presence in meat products, especially chicken [6,9,10,11], reinforcing the hypothesis of cross-contamination in the slaughterhouse and highlighting the zoonotic potential of these strains from meat products. The presence of P. mirabilis in meat may represent a threat to consumer health, especially when these strains harbor genes that confer resistance to clinically important antimicrobials.
The World Health Organization (WHO) declared that antimicrobial resistance is one of the greatest threats to global health [12], in which the non-rational use of these compounds in animal production accelerates the selection of resistant strains, with prospects for increase considerable in the coming years because of the intensification in the production of animal foods [13,14]. The selection and dissemination of antimicrobial-resistant bacteria is estimated to result in 10 million deaths annually by the year 2050, resulting in considerable economic loss [15]. Thus, studies aimed at monitoring antimicrobial resistance, in farm animals and their products and in human clinical practice, are of paramount importance in providing data that enables a better understanding of resistance and directing more effective interventions.
One of the major concerns are β-lactam-resistant strains that harbor genes for extended spectrum β-lactamases (ESBL) and the AmpC-type β-lactamases (AmpC). β-lactamases make treatment of infections more difficult since they inactivate several classes of antimicrobials, including penicillins, cephalosporins, and monobactams [16]. The genes that encode these β-lactamases are often found on mobile genetic elements, such as plasmids, facilitating horizontal transmission and global dissemination of these enzymes [17]. CTX-M, an ESBL variant, and CMY-2, an AmpC variant, have been highlighted as being globally widespread β-lactam-resistant strains, making them a cause for concern [16,18].
Therefore, this study aimed to evaluate the genotypic and phenotypic profile of antimicrobial resistance in P. mirabilis isolated from chicken, pork, beef, and UTI-CA. The focus was on ESBL- and AmpC-producing strains and their clonal relationship and association with other resistance genes, to establish if meats can be important sources of dissemination of antimicrobial resistant P. mirabilis in the community.

2. Results

2.1. Phenotypic Resistance to Antimicrobials

A total of 21 antimicrobials belonging to various classes were included in this study. The resistance profile of the isolates ranged from strains sensitive to all antimicrobials tested in chicken meat (n = 10), UTI-CA (n = 81), beef (n = 78) and pork (n = 28) to strains resistant to 17 antimicrobials in chicken meat and UTI-CA, 14 in swine, and 12 in beef. The resistance profile of the strains is shown in Supplementary Table S1. Chicken meat isolates exhibited higher rates of resistance to antimicrobials compared to isolates from beef, pork, and UTI-CA, except in the case of chloramphenicol and florfenicol, where pork isolates exhibited higher resistance rates (Figure 1). Statistical analysis confirmed that chicken isolates exhibited resistance to a greater number of antimicrobials than isolates from beef, pork, and UTI-CA (p < 0.05). Furthermore, pork isolates exhibited greater resistance to nalidixic acid, enrofloxacin, sulfamethoxazole-trimethoprim, chloramphenicol, and florfenicol than isolates from beef and UTI-CA (p < 0.05). Finally, UTI-CA isolates were more resistant to antimicrobials than beef isolates (p < 0.05).
Strains considered to be MDR showed a prevalence of 153 (76.5%) in chicken meat, 38 (46%) in pork, 6 (6%) in beef, and 59 (29.5%) in UTI-CA. Therefore, MDR strains tended to be more commonly found in chicken meat (OR: 9.75; CI: 5.95–13.17), followed by pork (OR: 4.13; CI: 2.57–6.64) and UTI-CA (OR: 2.8; IC: 1.82–4.31). The ESBL phenotype was confirmed in 47 chicken isolates (23.5%), 6 in pork (7.2%), 3 in beef (3%), and 19 in UTI-CA (9.5%). Regardless of the source of isolation, P. mirabilis carrying ESBL/AmpC were resistant to a greater number of antimicrobials (p < 0.05) when compared to non-producing strains (Figure 2 and Figure 3).

2.2. Detection of Antimicrobial Resistance Genes

All strains that expressed the ESBL phenotype were characterized by the production of CTX-M and the absence of SHV and TEM. Only the blaCTX-M-2 and blaCTX-M-65 variants (CTX-M-9 group) were detected in our study, the latter being the most prevalent variant in isolates from meat strains and UTI-CA (Table 1). No strain carried the CTX-M-2 and CTX-M-65 variants concurrently. Regarding AmpC, only blaCMY-2 was detected in chicken and UTI-CA, whereas no isolates of beef and pork harbored AmpC (Table 1).
P. mirabilis isolates with blaCTX-M (OR: 2.54; CI: 1.76–3.64) and blaCMY-2 (OR: 5.33; CI: 2.5–11.34) were more commonly found in chicken than in beef, pork, and UTI-CA. Although the more prevalence of ESBL/AmpC-producing strains in chicken meat is notable, it should be considered that chicken meat had significantly more P. mirabilis than pork and beef, which may have contributed to this result. More UTI-CA isolates were found to harbor blaCTX-M (OR: 1.41; CI: 0.95–2.08) and blaCMY-2. (OR: 1.65; CI: 0.3–1.41) compared to beef and pork isolates. Of the 26 blaCMY-2-producing isolates from chicken, 20 (76.9%) harbored a variant of blaCTX-M. Of the ten blaCMY-2-producing strains in UTI-CA, four (40%) also harbored blaCTX-M. This shows that the blaCMY-2 gene is more commonly found in blaCTX-M-producing strains than in non-producing strains, both in chicken (OR: 5.48; IC: 3.06–9.81) and UTI-CA (OR: 3.58; 1.51–8.48).
In addition to the detection of bla genes, other genes that confer resistance to non-β-lactam antimicrobials were also found in both chicken and UTI-CA, including fosA3, sul1, sul2, cmlA, floR, qnrD, and aac(6′)-Ib-cr. However, some of these genes were not detected in beef or pork isolates (Table 1). The fosA3, qnrD, sul1, and sul2 genes were more prevalent in chicken strains than in other sources (p < 0.05), whereas the floR gene was more prevalent in pork strains (p < 0.05). Pork strains also harbored more qnrD and sul2 genes than beef strains and UTI-CA (p < 0.05). Furthermore, blaCTX-M- and blaCMY-2-producing strains tend to have a greater number of resistance genes than the non-producing strains (Table 2). Interestingly, the fosA3 gene was detected only in blaCTX-M-65-producing strains, showing a direct correlation (r = 0.8711923) between blaCTX-M-65 and fosA3 in both chicken and UTI-CA (OR: >150; CI: 0.89–1.21). The qnrA, qnrB, qnrC, oqxA, oqxB, and cat genes were not detected in any isolate.

2.3. Molecular Typing of Isolates

PFGE of chromosomal DNA digested with Not I from the 87 bla gene containing isolates showed 11 clusters and 76 unique pulse types, demonstrating a high heterogeneity between strains (Figure 4). Among the 11 clusters that housed genetically related strains (similarity > 90%), clusters C01, C03, C04, C05, and C08 housed isolates from chicken and UTI-CA. No clusters harbored isolates from UTI-CA and beef or pork strains. The C01 cluster was composed of four chicken strains and two UTI-CA strains, all exhibiting the same phenotypic and genotypic antimicrobial resistance profile and the same plasmid replicon. Clusters C03, C04, C05, and C08 harbored isolates from chicken and UTI-CA, showing different plasmid resistance and replicon phenotypic and genotypic profiles amongst the clusters. Cluster C02 housed two identical strains isolated from pork sourced from the same butcher shop. C06 and C07 harbored only UTI-CA strains, which had different resistance profiles and were isolated from different basic health units (BHU). Cluster C09 housed two isolates from chicken from different butcher shops but with identical characteristics. Cluster C11 housed two strains of chicken with different characteristics and C10 housed two identical isolates from beef from the same butcher shop.

3. Discussion

Of all the sources surveyed in our study, the highest prevalence of resistance was found in chicken isolates (Figure 1), with greater than 50% showing resistance to antimicrobials belonging to the classes of penicillins, cephalosporins, sulfonamides, and quinolones. The high prevalence of antimicrobial-resistant P. mirabilis in chicken is a direct consequence of the use of antimicrobials in poultry [19,20]. Furthermore, although some antimicrobials are exclusive for veterinary use, such as florfenicol, enrofloxacin, and ceftiofur, they belong to the same class of antimicrobials that are used to treat infections in humans. This can cause cross-resistance, which makes actions integrated in the One Health concept essential to minimize the impact of resistance to antimicrobials [21,22].
It is important to highlight the high prevalence of resistance to chloramphenicol and florfenicol observed in pork isolates relative to isolates from chicken, beef, and UTI-CA (p < 0.05) (Figure 1). Recently, a high prevalence of resistance to chloramphenicol in swine isolates has been reported in some countries [23,24], including Brazil [25], which may be attributed to co-selection by florfenicol, which has been used for prophylactic purposes in pig farming in Brazil [25].
Among the sources researched in our study, chicken and pork were found to be an important risk factor for the spread of antimicrobial resistant P. mirabilis in humans, with higher prevalence of MDR compared to isolates from UTI-CA (p < 0.05). In addition, among the three types of meat surveyed, beef showed the fewest MDR isolates, which may be attributed to cattle rearing being an extensive production system with little use of antimicrobials, even for therapeutic purposes [22].
Our study detected a high prevalence of MDR isolates in chicken (76.5%), which was similar to the results from other studies carried out in Southern Brazil [26,27]. In addition, our study also showed an increase in antimicrobial resistance in P. mirabilis strains causing UTI-CA, and a study carried out by our research group in the same region in 2017 detected only 7.1% prevalence of MDR strains [28], whereas the present study, carried out with isolates from 2019, showed 29.5% MDR prevalence. The high prevalence of MDR strains detected in meat and the emergence of MDR strains in UTI-CA is alarming, as MDR strains are associated with higher mortality rates when compared to antimicrobial- sensitive strains [29]. Our study found the presence of strains carrying ESBL in all sources surveyed, but with different prevalence, with chicken showing the highest prevalence of 47 (23.5%) ESBL-producing isolates followed by UTI-CA with 19 (9.5%), indicating that chicken represents a high risk for the spread of ESBL-producing strains (OR: 2.54; CI: 1.76–3.64). The spread of ESBL-producing strains in chicken meat imported from Brazil has already been reported in Europe and Mozambique [30,31].
Among all ESBL detected in our study, the most prevalent was blaCTX-M-65 (group CTX-M-9), which was found in all sources, and the least prevalent was blaCTX-M-2 (group CTX-M-2), found only in strains isolated from chicken and human samples (Table 1). This indicates that meat strains and UTI-CA share the same ESBL variant. In contrast to these results, although blaCTX-M alleles tend to change in a region over time, other studies carried out with E. coli from broiler chickens and broiler meat in the same period in Brazil reported a higher prevalence of the CTX-M-2 group, followed by CTX-M-1 and CTX-M-8, as well as the absence of the CTX-M-9 group [26,27]. The presence of blaCTX-M-65 has already been identified in Enterobacterales isolated from meat and humans in several countries [32,33,34,35,36,37], whereas in Brazil, this variant has only been detected in zoo animals [38]. The blaCTX-M-65 variant has become one of the most dominant variants in farm animals and their products in China [39,40]. To our knowledge, this is the first study to detect the blaCTX-M-65 variant in P. mirabilis isolated from chicken, pork, beef, and UTI-CA.
The only AmpC detected in our study was blaCMY-2, which was found to be more prevalent in chicken isolates (OR: 5.33; CI: 2.5–11.34), making chicken an important risk factor for the spread of blaCMY-2, followed by UTI-CA (OR: 1.65; CI: 0.3–1.41). Pork and beef had no isolates harboring blaCMY-2. Interestingly, our study showed a high prevalence of isolates co-producing blaCTX-M and blaCMY-2 in chicken (76.9%) and UTI-CA (40%), indicating that chicken is an important source of dissemination of strains co-producing ESBL and AmpC. A previous study showed similar results on the coexistence of ESBL and AmpC, reporting a coexistence of 64.9% in E. coli isolated from chicken farms in Brazil [27]. Another study showed 30% of clinical isolates of E. coli and Klebsiella spp. in Iran exhibited the coexistence of ESBL and AmpC [41].
Notably, the ESBL-producing isolates in our study exhibited greater resistance to several other antimicrobials, including cephalosporins, quinolones, aminoglycosides, amphenicols, and fosfomycin (Figure 2). Similar results of E. coli causing UTI-CA [42] in chickens and pigs [43] were also reported. Likewise, blaCMY-2-producing strains also exhibited more resistance to several other antimicrobials compared to non-producing strains (Figure 3). These results deserve attention, as they show that the use of antimicrobials other than β-lactams in animal production can facilitate the co-selection and increase of ESBL-and AmpC-producing strains. Similar to our study, another study showed that E. coli strains producing blaCMY-2 isolated from chickens and humans have resistance to several antimicrobials other than β-lactams [44].
In addition, our study showed that meat is an important source of dissemination of antimicrobial resistance genes not related to β-lactamases (Table 1), especially chicken, which had more isolates with the fosA3, sul1, sul2, cmlA, and aac(6′)-Ib-cr compared to pork, beef, and UTI-CA (p < 0.05). It is important to highlight the high prevalence of sul2 and qnrD genes, which are responsible for the high frequency of resistance to sulfonamide and quinolones, respectively, in chicken isolates. The high prevalence of the qnrD gene in P. mirabilis has also been identified in chicken meat sold in the same region [10], showing that chicken produced in Southern Brazil can spread P. mirabilis with a high prevalence of this gene, which is commonly found in strains of the tribe Proteeae [45]. To our knowledge, this is the first study to report the high prevalence of the sul2 gene and the presence of fosA3, cmlA, and floR genes in P. mirabilis isolated from chicken meat. In addition, blaESB- and AmpC-producing strains had more genes resistant to non-β-lactam antimicrobials compared to non-producing strains (Table 2). This highlights the qnrD and sul2 genes, which were more prevalent in isolates with ESBL and AmpC in all sources studied. This indicates that the use of other antimicrobials, such as quinolones and sulfonamides, can enable the co-selection of other resistance genes.
The fact that our study identified a higher prevalence of the fosA3 gene in chicken (p < 0.05) reinforces the impact of the use of antimicrobials in poultry farming. As already evidenced by Gazal et al. [27], fosfomycin has been widely used in broiler chicken farms in the state of Paraná [27]. However, the findings regarding fosfomycin resistance in this study are very alarming, since it is one of the most used antimicrobials for the treatment of UTI-CA in countries such as Brazil, Belgium, Italy, and Russia [46]. Thus, our study proposes that fosfomycin use should be prohibited in poultry farming, since this antimicrobial has been one of the few alternatives for the treatment of infections caused by bacteria that produce β-lactamases and carbapenemases [29].
Recently, our research group demonstrated that several strains isolated from meat were similar to strains isolated from UTI-CA using the ERIC-PCR technique. This becomes even more aggravating when we consider the various fundamental virulence factors for the establishment of UTI in humans identified in these strains in another study by our group [11]. These results make clear the potential of P. mirabilis isolated from meat to cause UTI-CA. However, techniques that have better discriminatory power, as well as PFGE [47], can better contribute to the molecular typing of isolates and the identification of possible clones. As shown in Figure 4, only chicken isolates had a clonal relationship with UTI-CA isolates (clusters C01, C3, C4, C5, and C8), highlighting cluster C01, in which all six strains had the blaCTX-M-65, fosA3, aac(6′)-lb-cr, sul1, sul2, and cmlA, with two of these strains (one from chicken meat and one from UTI-CA) exhibiting 100% similarity. It is also important to note that C8 harbored a chicken isolate and a UTI-CA isolate that exhibited 100% similarity and carried blaCTX-M-2, blaCMY-2, qnrD, sul1, and sul2. Therefore, our study shows that chicken is an important source of P. mirabilis, carrying problematic antimicrobial resistance genes with the potential to cause UTI-CA.

4. Materials and Methods

4.1. Bacterial Isolates

In 2021, a study carried out by our research group isolated a total of 583 P. mirabilis strains from chicken (n = 200), beef (n = 100), pork (n = 83), and urine samples from humans with UTI-CA (n = 200) from the same geographical area (Londrina-PR/April to December 2019). All isolates selected for this study belonged to the bacteriological collection of the Laboratory of Bacteriology at the State University of Londrina (LABAC-UEL) and have been previously recorded [11].

4.2. Antimicrobial Susceptibility Test

The resistance profiles of all 583 isolates were evaluated by the disk diffusion method on Mueller–Hinton agar employing antimicrobials used in treatment of human infections as recommended by the Clinical and Laboratory Standards Institute (CLSI) [48]. The antimicrobials (Oxoid™, Basingstoke, Hants, UK) were ampicillin (AMP) 10 μg, amoxicillin + clavulanate (AMC) 20/10 μg, cephalothin (CEF) 30 μg, cefoxitin (CFO) 30 μg, ceftazidime (CAZ) 30 μg, ceftriaxone (CRO) 30 μg, cefepime (CPM) 30 μg, nalidixic acid (NAL) 30 μg, norfloxacin (NOR) 10 μg, ciprofloxacin (CIP) 5 μg, sulfamethoxazole-trimethoprim (SUT) 1.25/23.75 μg, aztreonam (ATM) 30 μg, chloramphenicol (CHL) 30 μg, gentamicin (GEN) 10 μg, tobramycin (TOB) 10 μg, amikacin (AMI), fosfomycin (FOS) 200 μg, and ertapenem (ETP) 10 μg. Additionally, the veterinary antimicrobials ceftiofur (CTF) 30 μg, enrofloxacin (ENO), and florfenicol (FFC) were also used [49]. The isolates were considered multidrug-resistant (MDR) when they exhibited resistance to three or more different classes of antimicrobials [50]. Strains resistant to third-generation cephalosporins were evaluated for ESBL production using the combined disk technique following CLSI recommendations [48]. E. coli ATCC 25922 was used for quality control.

4.3. Detection of Resistance Genes

The DNA of the isolates was extracted using the Pure Link® Genomic DNA Mini Kit (Invitrogen®, Waltham, MA, USA) and used in the polymerase chain reaction (PCR) technique to detect antimicrobial resistance genes. Isolates that exhibited phenotypic resistance to third-generation cephalosporins were subjected to detection of groups encoding CTX-M-1, 2, 8, 9, and 25; TEM; and SHV-type enzymes. Isolates suspected of producing AmpC were subjected to the detection of six specific plasmid-mediated families: ACC, CIT, DHA, EBC, FOX, and MOX. Additionally, isolates that showed resistance to other classes of antimicrobials were subjected to detection of the genes qnrA, qnrB, qnrC qnrS, qnrD, oqxA, oqxB, and qepA (quinolone resistance); aac(6′)-Ib-cr (quinolone/aminoglycosides resistance); sul1 and sul2 (sulfonamide resistance); and cat, cmlA and floR (amphenicol resistance). Information regarding the primers is shown in Supplementary Table S2. The PCR products were stained with SYBR Safe (Invitrogen®), subjected to electrophoresis on a 2% agarose gel, and visualized in a UV light transilluminator (Vilbert Lourmat™, Collégien, France).

4.4. Pulsed-Field Gel Electrophoresis (PFGE)

All ESBL and AmpC-producing isolates were subjected to molecular typing by pulsed-field gel electrophoresis (PFGE) using a procedure described on Pulsenet (https://www.cdc.gov/pulsenet/pathogens/pfge.html) [51] (accessed on 12 July 2022), with modifications. Briefly, bacterial suspension was prepared in sterile 0.9% NaCl, from which 100 µL was centrifuged at 16,000× g. The pellet was resuspended in 45 µL of TE buffer (10 mM Tris-HCl, pH 8, 1 mM EDTA) and 45 µL of CleanCut™ (Bio-RadTM, Hercules, CA, USA) 2% agarose solution at 56 °C. Later, the plugs were lysed with 20 mg/mL of proteinase K (InvitrogenTM Waltham, MA, USA) in TE buffer at 56 °C for 18 h. After serial washing with TE buffer, the genomic DNA in the lysis solution was digested with 50 U/pellet of Not I enzyme (Invitrogen TM Waltham, MA, USA) for 24 h at 37 °C. Electrophoresis was performed in a CHEF-DR® III device (Bio-RadTM, Hercules, CA, USA) under the following conditions: initial exchange time = 2.2 s, final exchange time = 54.2 s, inclined angle = 120°, and field electrical power = 6 V/cm for 24 h. The electrophoresis result was visualized after staining with 0.5 µg/mL of ethidium bromide. The dendrogram was built in BioNumerics™ (Applied Maths, Sint-Martens-Latem, BE, USA) version 7.6.3 software with 0% optimization and 1% tolerance. The genetic similarity of the isolates was determined by the Dice similarity index and the dendrogram was constructed using the unweighted pair group method with arithmetic mean (UPGMA). Isolates were considered genetically related when the similarity coefficient was ≥90%.

4.5. Sequencing of ESBL and blaCMY

The ESBL and AmpC products were purified with the PureLink™ PCR Purification Kit (InvitrogenTM Waltham, MA, USA) and subjected to Sanger ABI-PRISM 3500 XL bidirectional sequencing (Applied Biosystems®, Foster City, CA, USA). β-lactamase variants were identified after evaluating sequence homology using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) [52] (accessed on 12 November 2021).

4.6. Statistical Analysis

Multivariate logistic regression analysis and odds ratios (OR) were used to assess possible correlations between the isolation sources and the chosen variables (MDR, resistance genes). The calculation of Odds Ratio was performed using the epiDisplay package (version 3.5.0.1), where the categorical data of binomial distribution, modeled by a logistic regression, working with the entire dataset of the four sources, using the stats package (version 4.1.1), and the predictive values for OR calculation were analyzed, as well as their statistical significance via the Likelihood-ratio test (LR-test). The prevalence of antimicrobial resistance between sources and differences between ESBL- and AmpC-producing strains and non-producing strains were compared using Pearson’s Chi-square and Fisher’s test. Statistical analysis was performed using R v3.6.3 software, with a 95% confidence interval (CI). Differences were considered significant at p < 0.05.

5. Conclusions

In conclusion, P. mirabilis isolated from chicken, pork, and beef may exhibit resistance to multiple antimicrobials of human clinical importance. Of the three types of meat evaluated, the chicken meat was the main source of P. mirabilis resistant to a variety of antimicrobials, including P. mirabilis harboring blaCTX-M-65, blaCTX-M-2, blaCMY-2, and several other resistance genes that were also found in UTI-CA strains. Furthermore, the genetic similarity between chicken meat isolates and UTI-CA isolates indicates the circulation of strains between these sources, showing that the isolation of P. mirabilis from meat should not be neglected. In this sense, studies aimed at the frequent monitoring of resistance to antimicrobials in animal production and their products, as well as in humans, are of paramount importance to minimize the impact of this phenomenon and ensure the one health approach.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics12020370/s1, Table S1: Phenotypic and genotypic profile of antimicrobial resistance of P. mirabilis isolated from meat and UTI-CA; Table S2: Sequence of primers used to detect antimicrobial resistance genes (References [53,54,55,56,57,58,59,60,61,62,63] are cited in supplementary materials).

Author Contributions

Conceptualization, M.S.S. and S.P.D.R.; methodology, C.R.d.S., L.C.S., V.H.M. and B.H.D.d.O.; software, G.H.M.G.; validation, M.S.S., M.F.M.-C., C.R.d.S. and L.C.S.; formal analysis, M.S.S., L.C.S. and B.H.D.d.O.; investigation, M.S.S. and M.F.M.-C.; resources, M.S.S. and S.P.D.R.; writing—original draft preparation, M.S.S., M.C.L.N., R.K.T.K. and E.C.V.; writing—review and editing, R.K.T.K., E.C.V. and S.P.D.R.; visualization, E.C.V. and S.P.D.R.; supervision, S.P.D.R.; project administration, E.C.V. and S.P.D.R.; funding acquisition, E.C.V. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially supported by the Bill and Melinda Gates Foundation (number OPP1193112). Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Grant is part of Grand Challenges Explorations Brazil—New Approaches to Characterize the Global Burden of Antimicrobial Resistance (OPP1193112); and by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee of Londrina State University (protocol code 1.590.120).

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Drzewiecka, D. Significance and roles of Proteus spp. bacteria in natural environments. Microb. Ecol. 2016, 72, 741–758. [Google Scholar] [CrossRef]
  2. Schaffer, J.N.; Pearson, M.M. Urinary tract infections: Molecular pathogenesis and clinical management. In Urinary Tract Infections, 2nd ed.; Mulvey, M.A., Klumpp, D.J., Stapleton, A.E., Eds.; ASM Press: Washington, DC, USA, 2017; pp. 383–434. [Google Scholar]
  3. Armbruster, C.E.; Mobley, H.L.T.; Pearson, M.M. Pathogenesis of Proteus mirabilis infection. EcoSal. Plus 2018, 8, 01–73. [Google Scholar] [CrossRef]
  4. Gajdács, M.; Urbán, E. Comparative epidemiology and resistance trends of Proteae in urinary tract infections of inpatients and outpatients: A 10-year retrospective study. Antibiotics 2019, 8, 91. [Google Scholar] [CrossRef] [PubMed]
  5. Reu, C.E.; Volanski, W.; Prediger, K.C.; Picheth, G.; Fadel-Picheth, C.M.T. Epidemiology of pathogens causing urinary tract infections in an urban community in southern Brazil. Braz. J. Infect. Dis. 2018, 22, 505–507. [Google Scholar] [CrossRef]
  6. Yu, Z.; Joossens, M.; Van den Abeele, A.-M.; Kerkhof, P.-J.; Houf, K. Isolation, characterization and antibiotic resistance of Proteus mirabilis from belgian broiler carcasses at retail and human stool. Food. Microbiol. 2021, 96, 103724. [Google Scholar] [CrossRef]
  7. Tesson, V.; Federighi, M.; Cummins, E.; de Oliveira Mota, J.; Guillou, S.; Boué, G. A systematic review of beef meat quantitative microbial risk assessment models. Int. J. Environ. Res. Public Health 2020, 17, 688. [Google Scholar] [CrossRef]
  8. Baéza, E.; Guillier, L.; Petracci, M. Review: Production factors affecting poultry carcass and meat quality attributes. Animal 2022, 16, 100331. [Google Scholar] [CrossRef]
  9. Guo, S.; Aung, K.T.; Tay, M.Y.F.; Seow, K.L.G.; Ng, L.C.; Schlundt, J. Extended-spectrum β-lactamase-producing Proteus mirabilis with multidrug resistance isolated from raw chicken in Singapore: Genotypic and phenotypic analysis. J. Glob. Antimicrob. Resist. 2019, 19, 252–254. [Google Scholar] [CrossRef] [PubMed]
  10. Sanches, M.S.; Baptista, A.A.S.; de Souza, M.; Menck-Costa, M.F.; Koga, V.L.; Kobayashi, R.K.T.; Rocha, S.P.D. Genotypic and phenotypic profiles of virulence factors and antimicrobial resistance of Proteus mirabilis isolated from chicken carcasses: Potential zoonotic risk. Braz. J. Microbiol. 2019, 50, 685–694. [Google Scholar] [CrossRef] [PubMed]
  11. Sanches, M.S.; Rodrigues da Silva, C.; Silva, L.C.; Montini, V.H.; Lopes Barboza, M.G.; Guidone, G.H.M.; Dias de Oliva, B.H.; Nishio, E.K.; Faccin Galhardi, L.C.; Vespero, E.C.; et al. Proteus mirabilis from community-acquired urinary tract infections (UTI-CA) shares genetic similarity and virulence factors with isolates from chicken, beef and pork meat. Microb. Pathog. 2021, 158, 105098. [Google Scholar] [CrossRef] [PubMed]
  12. Antimicrobial Resistance: Global Report on Surveillance. Available online: https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf;jsessionid=9BD9CFC92083023155E1028C22D10F1F?sequence=1 (accessed on 12 November 2021).
  13. Di, K.N.; Pham, D.T.; Tee, T.S.; Binh, Q.A.; Nguyen, T.C. Antibiotic usage and resistance in animal production in Vietnam: A review of existing literature. Trop. Anim. Health Prod. 2021, 53, 340. [Google Scholar] [CrossRef] [PubMed]
  14. Kasimanickam, V.; Kasimanickam, M.; Kasimanickam, R. Antibiotics use in food animal production: Escalation of antimicrobial resistance: Where are we now in combating AMR? Med. Sci. 2021, 9, 14. [Google Scholar] [CrossRef]
  15. O’Neill, J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. Available online: https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf (accessed on 12 November 2021).
  16. Castanheira, M.; Simner, P.J.; Bradford, P.A. Extended-spectrum β-lactamases: An update on their characteristics, epidemiology and detection. JAC-Antimicrob. Resist. 2021, 3, 3. [Google Scholar] [CrossRef]
  17. Madec, J.-Y.; Haenni, M.; Nordmann, P.; Poirel, L. Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: A threat for humans? Clin. Microbiol. Infect. 2017, 23, 826–833. [Google Scholar] [CrossRef] [PubMed]
  18. Bush, K.; Bradford, P.A. Epidemiology of β-lactamase-producing pathogens. Clin. Microbiol. Rev. 2020, 33, 2. [Google Scholar] [CrossRef]
  19. Nhung, N.T.; Chansiripornchai, N.; Carrique-Mas, J.J. Antimicrobial resistance in bacterial poultry pathogens: A review. Front. Vet. Sci. 2017, 4, 126. [Google Scholar] [CrossRef] [PubMed]
  20. Hedman, H.D.; Vasco, K.A.; Zhang, L. A review of antimicrobial resistance in poultry farming within low-resource settings. Animals 2020, 10, 1264. [Google Scholar] [CrossRef]
  21. Roth, N.; Käsbohrer, A.; Mayrhofer, S.; Zitz, U.; Hofacre, C.; Domig, K.J. The application of antibiotics in broiler production and the resulting antibiotic resistance in Escherichia coli: A global overview. Poult. Sci. 2019, 98, 1791–1804. [Google Scholar] [CrossRef] [PubMed]
  22. Rabello, R.F.; Bonelli, R.R.; Penna, B.A.; Albuquerque, J.P.; Souza, R.M.; Cerqueira, A.M.F. Antimicrobial resistance in farm animals in Brazil: An update overview. Animals 2020, 10, 552. [Google Scholar] [CrossRef] [PubMed]
  23. Faccone, D.; Moredo, F.A.; Giacoboni, G.I.; Albornoz, E.; Alarcón, L.; Nievas, V.F.; Corso, A. Multidrug-resistant Escherichia coli harbouring mcr-1 and blaCTX-M genes isolated from swine in Argentina. J. Glob. Antimicrob. Resist. 2019, 18, 160–162. [Google Scholar] [CrossRef]
  24. Abdalla, S.E.; Abia, A.L.K.; Amoako, D.G.; Perrett, K.; Bester, L.A.; Essack, S.Y. From farm-to-fork: E. coli from an intensive pig production system in South Africa shows high resistance to critically important antibiotics for human and animal use. Antibiotics 2021, 10, 178. [Google Scholar] [CrossRef] [PubMed]
  25. Viana, C.; Grossi, J.L.; Sereno, M.J.; Yamatogi, R.S.; Bersot, L.D.S.; Call, D.R.; Nero, L.A. Phenotypic and genotypic characterization of non-typhoidal Salmonella isolated from a brazilian pork production chain. Food Res. Int. 2020, 137, 109406. [Google Scholar] [CrossRef] [PubMed]
  26. Cyoia, P.S.; Koga, V.L.; Nishio, E.K.; Houle, S.; Dozois, C.M.; de Brito, K.C.T.; de Brito, B.G.; Nakazato, G.; Kobayashi, R.K.T. Distribution of ExPEC virulence factors, blaCTX-M, fosA3, and mcr-1 in Escherichia coli isolated from commercialized chicken carcasses. Front. Microbiol. 2018, 9, 3254. [Google Scholar] [CrossRef] [PubMed]
  27. de Souza Gazal, L.E.; Medeiros, L.P.; Dibo, M.; Nishio, E.K.; Koga, V.L.; Gonçalves, B.C.; Grassotti, T.T.; de Camargo, T.C.L.; Pinheiro, J.J.; Vespero, E.C.; et al. Detection of ESBL/AmpC-producing and fosfomycin-resistant Escherichia coli from different sources in poultry production in southern Brazil. Front. Microbiol. 2020, 11, 604544. [Google Scholar] [CrossRef]
  28. Oliveira, W.D.; Barboza, M.G.L.; Faustino, G.; Inagaki, W.T.Y.; Sanches, M.S.; Kobayashi, R.K.T.; Vespero, E.C.; Rocha, S.P.D. Virulence, resistance and clonality of Proteus mirabilis isolated from patients with community-acquired urinary tract infection (CA-UTI) in Brazil. Microb. Pathog. 2021, 152, 104642. [Google Scholar] [CrossRef]
  29. Rodríguez-Baño, J.; Gutiérrez-Gutiérrez, B.; Machuca, I.; Pascual, A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Rev. 2018, 31, 2. [Google Scholar] [CrossRef]
  30. Dhanji, H.; Murphy, N.M.; Doumith, M.; Durmus, S.; Lee, S.S.; Hope, R.; Woodford, N.; Livermore, D.M. Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. J. Antimicrob. Chemother. 2010, 65, 2534–2537. [Google Scholar] [CrossRef]
  31. Faife, S.L.; Zimba, T.; Sekyere, J.O.; Govinden, U.; Chenia, H.Y.; Simonsen, G.S.; Sundsfjord, A.; Essack, S.Y. β-lactam and fluoroquinolone resistance in Enterobacteriaceae from imported and locally-produced chicken in Mozambique. J. Infect. Dev. Ctries. 2020, 14, 471–478. [Google Scholar] [CrossRef]
  32. Park, H.; Kim, J.; Ryu, S.; Jeon, B. Predominance of blaCTX-M-65 and blaCTX-M-55 in extended-spectrum β-lactamase-producing Escherichia coli from raw retail chicken in South Korea. J. Glob. Antimicrob. Resist. 2019, 17, 216–220. [Google Scholar] [CrossRef]
  33. Leão, C.; Clemente, L.; Moura, L.; Seyfarth, A.M.; Hansen, I.M.; Hendriksen, R.S.; Amaro, A. Emergence and clonal spread of CTX-M-65-Producing Escherichia coli from retail meat in Portugal. Front. Microbiol. 2021, 12, 653595. [Google Scholar] [CrossRef]
  34. Hounmanou, Y.M.G.; Bortolaia, V.; Dang, S.T.T.; Truong, D.; Olsen, J.E.; Dalsgaard, A. ESBL and AmpC β-lactamase encoding genes in E. coli from pig and pig farm workers in Vietnam and their Association with mobile genetic elements. Front. Microbiol. 2021, 12, 629139. [Google Scholar] [CrossRef] [PubMed]
  35. Tate, H.; Folster, J.P.; Hsu, C.-H.; Chen, J.; Hoffmann, M.; Li, C.; Morales, C.; Tyson, G.H.; Mukherjee, S.; Brown, A.C.; et al. Comparative analysis of extended-spectrum-β-lactamase CTX-M-65-producing Salmonella enterica Serovar Infantis isolates from humans, food animals, and retail chickens in the United States. Antimicrob. Agents Chemother. 2017, 61, 7. [Google Scholar] [CrossRef] [PubMed]
  36. Vinueza-Burgos, C.; Ortega-Paredes, D.; Narváez, C.; De Zutter, L.; Zurita, J. Characterization of cefotaxime resistant Escherichia coli isolated from broiler farms in Ecuador. PLoS ONE 2019, 14, 4. [Google Scholar] [CrossRef]
  37. Martínez-Puchol, S.; Riveros, M.; Ruidias, K.; Granda, A.; Ruiz-Roldán, L.; Zapata-Cachay, C.; Ochoa, T.J.; Pons, M.J.; Ruiz, J. Dissemination of a multidrug resistant CTX-M-65 producer Salmonella enterica Serovar Infantis clone between marketed chicken meat and children. Int. J. Food Microbiol. 2021, 344, 109109. [Google Scholar] [CrossRef] [PubMed]
  38. Furlan, J.P.R.; Lopes, R.; Gonzalez, I.H.L.; Ramos, P.L.; Stehling, E.G. Comparative analysis of multidrug resistance plasmids and genetic background of CTX-M-producing Escherichia coli recovered from captive wild animals. Appl. Microbiol. Biotechnol. 2020, 104, 6707–6717. [Google Scholar] [CrossRef] [PubMed]
  39. Wang, J.; Zeng, Z.-L.; Huang, X.-Y.; Ma, Z.-B.; Guo, Z.-W.; Lv, L.-C.; Xia, Y.-B.; Zeng, L.; Song, Q.-H.; Liu, J.-H. Evolution and comparative genomics of F33:A-:B- plasmids carrying blaCTX-M-55 or blaCTX-M-65 in Escherichia coli and Klebsiella pneumoniae isolated from animals, food products, and humans in China. mSphere 2018, 3, 4. [Google Scholar] [CrossRef]
  40. Wu, C.; Wang, Y.; Shi, X.; Wang, S.; Ren, H.; Shen, Z.; Wang, Y.; Lin, J.; Wang, S. Rapid rise of the ESBL and mcr-1 Genes in Escherichia coli of chicken origin in China, 2008–2014. Emerg. Microbes Infect. 2018, 7, 1. [Google Scholar] [CrossRef]
  41. Rizi, K.S.; Mosavat, A.; Youssefi, M.; Jamehdar, S.A.; Ghazvini, K.; Safdari, H.; Amini, Y.; Farsiani, H. High prevalence of blaCMY AmpC beta-lactamase in ESBL co-producing Escherichia coli and Klebsiella spp. clinical isolates in the northeast of Iran. J. Glob. Antimicrob. Resist. 2020, 22, 477–482. [Google Scholar] [CrossRef]
  42. Kumar, N.; Chatterjee, K.; Deka, S.; Shankar, R.; Kalita, D. Increased isolation of extended-spectrum beta-lactamase-producing Escherichia coli from community-onset urinary tract infection cases in Uttarakhand, India. Cureus 2021, 13, 3. [Google Scholar] [CrossRef]
  43. Kimera, Z.I.; Mgaya, F.X.; Misinzo, G.; Mshana, S.E.; Moremi, N.; Matee, M.I.N. Multidrug-resistant, including extended-spectrum beta lactamase-producing and quinolone-Resistant, Escherichia coli isolated from poultry and domestic pigs in Dar Es Salaam, Tanzania. Antibiotics 2021, 10, 406. [Google Scholar] [CrossRef] [PubMed]
  44. Koga, L.; Maluta, R.P.; da Silveira, W.D.; Ribeiro, R.A.; Hungria, M.; Vespero, E.C.; Nakazato, G.; Kobayashi, R.K.T. Characterization of CMY-2-type beta-lactamase-producing Escherichia coli isolated from chicken carcasses and human infection in a city of south Brazil. BMC Microbiol. 2019, 19, 174. [Google Scholar] [CrossRef] [PubMed]
  45. Kraychete, G.B.; Campana, E.H.; Picão, R.C.; Bonelli, R.R. qnrD-Harboring plasmids in Providencia spp. recovered from food and environmental brazilian sources. Sci. Total Environ. 2019, 646, 1290–1292. [Google Scholar] [CrossRef] [PubMed]
  46. Cai, T.; Palagin, I.; Brunelli, R.; Cipelli, R.; Pellini, E.; Truzzi, J.C.; Van Bruwaene, S. Office-Based approach to urinary tract infections in 50.000 patients: Results from the REWIND study. Int. J. Antimicrob. Agents 2020, 56, 105966. [Google Scholar] [CrossRef] [PubMed]
  47. Michelim, L.; Muller, G.; Zacaria, J.; Delamare, A.P.L.; da Costa, S.O.P.; Echeverrigaray, S. Comparison of PCR-based molecular markers for the characterization of Proteus mirabilis clinical isolates. Braz. J. Infect. Dis. 2008, 12, 423–429. [Google Scholar] [CrossRef] [PubMed]
  48. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Approved Standard; thirty-first Informational Supplement; CLSI Document M100-S31; CLSI: Wayne, PA, USA, 2021. [Google Scholar]
  49. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard; Third Informational Supplement; CLSI Document M31-A3; CLSI: Wayne, PA, USA, 2008. [Google Scholar]
  50. Magiorakos, A.-P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef] [PubMed]
  51. Standard Operating Procedure for PulseNet PFGE of Escherichia coli O157:H7, Escherichia coli non-O157 (STEC), Salmonella serotypes, Shigella sonnei and Shigella flexneri. Available online: https://www.cdc.gov/pulsenet/pathogens/pfge.html (accessed on 12 July 2022).
  52. Basic Local Alignment Search Tool (BLAST). Available online: http://blast.ncbi.nlm.nih.gov/Blast.cgi (accessed on 12 November 2021).
  53. Dallenne, C.; Da Costa, A.; Decré, D.; Favier, C.; Arlet, G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 2010, 65, 490–495. [Google Scholar] [CrossRef]
  54. Arlet, G.; Philippon, A. Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB). FEMS Microbiol. Lett. 1991, 82, 19–25. [Google Scholar] [CrossRef]
  55. Saladin, M.; Cao, V.T.B.; Lambert, T.; Donay, J.-L.; Herrmann, J.-L.; Ould-Hocine, Z.; Verdet, C.; Delisle, F.; Philippon, A.; Arlet, G. Diversity of CTX-M β-lactamases and their promoter regions fromEnterobacteriaceaeisolated in three Parisian hospitals. FEMS Microbiol. Lett. 2002, 209, 161–168. [Google Scholar] [CrossRef] [PubMed]
  56. Pérez-Pérez, F.J.; Hanson, N.D. Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR. J. Clin. Microbiol. 2002, 40, 2153–2162. [Google Scholar] [CrossRef]
  57. Cattoir, V.; Poirel, L.; Rotimi, V.; Soussy, C.-J.; Nordmann, P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 2007, 60, 394–397. [Google Scholar] [CrossRef] [Green Version]
  58. Wang, M.; Guo, Q.; Xu, X.; Wang, X.; Ye, X.; Wu, S.; Hooper, D.C.; Wang, M. New Plasmid-Mediated Quinolone Resistance Gene, qnrC, Found in a Clinical Isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 2009, 53, 1892–1897. [Google Scholar] [CrossRef] [PubMed]
  59. Cavaco, L.M.; Hasman, H.; Xia, S.; Aarestrup, F.M. qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin. Antimicrob. Agents Chemother. 2009, 53, 603–608. [Google Scholar] [CrossRef] [PubMed]
  60. Chen, X.; Zhang, W.; Pan, W.; Yin, J.; Pan, Z.; Gao, S.; Jiao, X. Prevalence of qnr, aac(6 ′ )-Ib-cr, qepA, and oqxAB in Escherichia coli Isolates from Humans, Animals, and the Environment. Antimicrob. Agents Chemother. 2012, 56, 3423–3427. [Google Scholar] [CrossRef] [PubMed]
  61. Li, Q.; Sherwood, J.; Logue, C. Characterization of antimicrobial resistant Escherichia coli isolated from processed bison carcasses. J. Appl. Microbiol. 2007, 103, 2361–2369. [Google Scholar] [CrossRef]
  62. Guerra, B.; Soto, S.M.; Argüelles, J.M.; Mendoza, M.C. Multidrug Resistance Is Mediated by Large Plasmids Carrying a Class 1 Integron in the Emergent Salmonella enterica Serotype [4,5,12:i:−]. Antimicrob. Agents Chemother. 2001, 45, 1305–1308. [Google Scholar] [CrossRef]
  63. Sato, N.; Kawamura, K.; Nakane, K.; Wachino, J.-I.; Arakawa, Y. First Detection of Fosfomycin Resistance Gene fosA3 in CTX-M-Producing Escherichia coli Isolates from Healthy Individuals in Japan. Microb. Drug Resist. 2013, 19, 477–482. [Google Scholar] [CrossRef]
Antibiotics 12 00370 g001 550
Figure 1. Comparison of the prevalence (%) of antimicrobial resistance in P. mirabilis isolated from chicken (n = 200), pork (n = 83), beef (n = 100), and UTI-CA (n = 200).
Figure 1. Comparison of the prevalence (%) of antimicrobial resistance in P. mirabilis isolated from chicken (n = 200), pork (n = 83), beef (n = 100), and UTI-CA (n = 200).
Antibiotics 12 00370 g001
Antibiotics 12 00370 g002 550
Figure 2. Antimicrobial resistance exhibited by ESBL-producing and non-ESBL-producing P. mirabilis strains isolated from chicken, pork, beef, and UTI-CA. * p < 0.05 by Fisher test.
Figure 2. Antimicrobial resistance exhibited by ESBL-producing and non-ESBL-producing P. mirabilis strains isolated from chicken, pork, beef, and UTI-CA. * p < 0.05 by Fisher test.
Antibiotics 12 00370 g002
Antibiotics 12 00370 g003 550
Figure 3. Antimicrobial resistance exhibited by AmpC-producing and non-AmpC-producing P. mirabilis strains isolated from chicken, pork, beef, and UTI-CA. * p < 0.05 by Fisher test.
Figure 3. Antimicrobial resistance exhibited by AmpC-producing and non-AmpC-producing P. mirabilis strains isolated from chicken, pork, beef, and UTI-CA. * p < 0.05 by Fisher test.
Antibiotics 12 00370 g003
Antibiotics 12 00370 g004 550
Figure 4. Dendrogram obtained from Not I-PFGE typing of the 87 P. mirabilis ESBL-AmpC producers. Dendrogram was constructed using optimization 0% and tolerance 1.5%. SXT: sulfamethoxazole-trimethoprim; AMC: amoxicillin and clavulanate; AMP: ampicillin; CEF: cephalothin; FOX: cefoxitin; CRO: ceftriaxone; CAZ: ceftazidime; CFT: ceftiofur; CPM: cefepime; ATM: aztreonam; NAL: nalidixic acid; ENO: enrofloxacin; CIP: ciprofloxacin; NOR: norfloxacin; CHL: chloramphenicol; FFC: florfenicol; GEN: gentamicin; TOB: tobramycin; FOS: fosfomycin; AMI: amikacin; ETP: ertapenem; C.P: collect point.
Figure 4. Dendrogram obtained from Not I-PFGE typing of the 87 P. mirabilis ESBL-AmpC producers. Dendrogram was constructed using optimization 0% and tolerance 1.5%. SXT: sulfamethoxazole-trimethoprim; AMC: amoxicillin and clavulanate; AMP: ampicillin; CEF: cephalothin; FOX: cefoxitin; CRO: ceftriaxone; CAZ: ceftazidime; CFT: ceftiofur; CPM: cefepime; ATM: aztreonam; NAL: nalidixic acid; ENO: enrofloxacin; CIP: ciprofloxacin; NOR: norfloxacin; CHL: chloramphenicol; FFC: florfenicol; GEN: gentamicin; TOB: tobramycin; FOS: fosfomycin; AMI: amikacin; ETP: ertapenem; C.P: collect point.
Antibiotics 12 00370 g004
Table
Table 1. Prevalence of resistance genes detected in P. mirabilis isolated from chicken (n = 200), pork (n = 83), beef (n = 100), and UTI-CA (n = 200).
Table 1. Prevalence of resistance genes detected in P. mirabilis isolated from chicken (n = 200), pork (n = 83), beef (n = 100), and UTI-CA (n = 200).
AntimicrobialsGenesChicken MeatPorkBeefHuman
β-lactamsblaCTX-M-214 (7.0%)0 (0.0%)0 (0.0%)5 (2.5%)
blaCTX-M-6533 (16.5%)6 (7.2%)3 (3.0%)14 (7.0%)
blaCMY-226 (13.0%)0 (0.0%)0 (0.0%)9 (4.5%)
FosfomycinfosA330 (15.0%)0 (0.0%)0 (0.0%)11 (5.5%)
Sulfonamidessul157 (28.5%)9 (10.8%)2 (2.0%)19 (9.5%)
sul2124 (62.0%)31 (37.3%)13 (13.0%)46 (23.0%)
AmphenicolscmlA36 (18.0%)6 (7.2%)0 (0.0%)21 (10.5%)
floR6 (3.0%)50 (60.2%)0 (0.0%)14 (7.0%)
QuinolonesqnrD125 (62.5%)26 (31.3%)10 (10.0%)34 (17.0%)
Aminoglycosides/quinolonesaac(6′)-Ib-cr24 (12.0%)0 (0.0%)0 (0.0%)11 (5.5%)
Table
Table 2. Distribution of non-β-lactam antimicrobial resistance genes in ESBL/AmpC-producing and non-ESBL/AmpC-producing P. mirabilis strains isolated from chicken, beef, pork and UTI-CA.
Table 2. Distribution of non-β-lactam antimicrobial resistance genes in ESBL/AmpC-producing and non-ESBL/AmpC-producing P. mirabilis strains isolated from chicken, beef, pork and UTI-CA.
SourcesResistance Genes
ESBL/AmpCfosA3sul1sul2cmlAfloRqnrDaac(6′)-Ib-cr
Chicken meatESBL30 (64%) *26 (55%) *43 (91%) *31 (66%) *(-)45 (96%) *17 (36%) *
Non-ESBL(-)31 (20%)81 (53%)5 (3%)6 (4%)80 (52%)7 (5%)
AmpC13 (50%) *14 (54%) *23 (88%) *14 (54%) *(-)24 (92%) *7 (27%) *
Non-AmpC17 (10%)43 (25%)101 (58%)22 (13%)6 (3%)101 (58%)17 (10%)
PorkESBL(-)(-)5 (83%) *1 (17%)5 (83%)5 (83%) *(-)
Non-ESBL(-)9 (12%)26 (34%)5 (6%)45 (58 %)21 (27%)(-)
AmpC(-)(-)(-)(-)(-)(-)(-)
Non-AmpC(-)9 (11%)31 (37%)6 (7%)50 (60%) *26 (31%)(-)
BeefESBL0 (0%)(-)3 (100%) *(-)(-)3 (100%) *(-)
Non-ESBL0 (0)2 (2%)10 (10%)(-)(-)7 (7%)(-)
AmpC(-)(-)(-)(-)(-)(-)(-)
Non-AmpC(-)2 (2%)13 (13%)(-)(-)10 (10%)(-)
HumanESBL11 (58%) *4 (21%)19 (100%) *9 (47%) *(-)19 (100%) *6 (32%) *
Non-ESBL(-)15 (8%)27 (15%)12 (7%)14 (8%)15 (8%)5 (3%)
AmpC1 (10%)4 (40%)8 (80%) *4 (40%)(-)7 (70%) *3 (30%)
Non-AmpC10 (5%)15 (8%)38 (20%)17 (9%)14 (7%)27 (14%)8 (4%)
*: Indicates significant difference; (-): Non-β-lactam antimicrobial resistance gene not detected.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sanches, M.S.; Silva, L.C.; Silva, C.R.d.; Montini, V.H.; Oliva, B.H.D.d.; Guidone, G.H.M.; Nogueira, M.C.L.; Menck-Costa, M.F.; Kobayashi, R.K.T.; Vespero, E.C.; et al. Prevalence of Antimicrobial Resistance and Clonal Relationship in ESBL/AmpC-Producing Proteus mirabilis Isolated from Meat Products and Community-Acquired Urinary Tract Infection (UTI-CA) in Southern Brazil. Antibiotics 2023, 12, 370. https://doi.org/10.3390/antibiotics12020370

AMA Style

Sanches MS, Silva LC, Silva CRd, Montini VH, Oliva BHDd, Guidone GHM, Nogueira MCL, Menck-Costa MF, Kobayashi RKT, Vespero EC, et al. Prevalence of Antimicrobial Resistance and Clonal Relationship in ESBL/AmpC-Producing Proteus mirabilis Isolated from Meat Products and Community-Acquired Urinary Tract Infection (UTI-CA) in Southern Brazil. Antibiotics. 2023; 12(2):370. https://doi.org/10.3390/antibiotics12020370

Chicago/Turabian Style

Sanches, Matheus Silva, Luana Carvalho Silva, Caroline Rodrigues da Silva, Victor Hugo Montini, Bruno Henrique Dias de Oliva, Gustavo Henrique Migliorini Guidone, Mara Corrêa Lelles Nogueira, Maísa Fabiana Menck-Costa, Renata Katsuko Takayama Kobayashi, Eliana Carolina Vespero, and et al. 2023. "Prevalence of Antimicrobial Resistance and Clonal Relationship in ESBL/AmpC-Producing Proteus mirabilis Isolated from Meat Products and Community-Acquired Urinary Tract Infection (UTI-CA) in Southern Brazil" Antibiotics 12, no. 2: 370. https://doi.org/10.3390/antibiotics12020370

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop